Journal of Viral Hepatitis

The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection
pp. 675-687(13)
Authors: Zeremski, M.; Petrovic, L. M.; Talal, A. H.

Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis
pp. 688-696(9)
Authors: Butt, A. A.; Skanderson, M.; McGinnis, K. A.; Ahuja, T.; Bryce, C. L.; Barnato, A. E.; Chang, C.-C. H.

The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies
pp. 697-703(7)
Authors: Fabrizi, F.; Takkouche, B.; Lunghi, G.; Dixit, V.; Messa, P.; Martin, P.

Safety and efficacy of an induction dose of pegylated interferon alpha-2a on early hepatitis C virus kinetics in HIV/HCV co-infected patients: the CORAL-1 multicentre pilot study
pp. 704-713(10)
Authors: Tural, C.; Solà, R.; Rubio, R.; Santín, M.; Planas, R.; Quereda, C.; Berenguer, J.; Montes-Ramírez, M.; Clotet, B.

Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease
pp. 714-720(7)
Authors: Masarone, M.; La Mura, V.; Bruno, S.; Gaeta, G. B.; Vecchione, R.; Carrino, F.; Moschella, F.; Torella, R.; Persico, M.

Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C
pp. 721-729(9)
Authors: Di Bisceglie, A. M.; Ghalib, R. H.; Hamzeh, F. M.; Rustgi, V. K.

Characteristics and survival of HIV-infected patients not screened for hepatitis C virus infection in a hospital-based cohort
pp. 730-735(6)
Authors: Bénet, T.; DOliveira, A.; Voirin, N.; Livrozet, J.-M.; Cotte, L.; Peyramond, D.; Chidiac, C.; Touraine, J.-L.; Fabry, J.; Trepo, C.; Allard, R.; Vanhems, P.

Cryoglobulinaemia associated with hepatitis C virus: influence of HCV genotypes, HCV-RNA viraemia and HIV coinfection
pp. 736-742(7)
Authors: Ramos-Casals, M.; Forns, X.; Brito-Zerón, P.; Vargas, A.; Ruiz, M.; Laguno, M.; Yagüe, J.; Mª Sánchez-Tapias, J.; Mª Gatell, J.; Font, J.

In vivo immunization in combination with peg-interferon for chronic hepatitis B virus infection
pp. 743-749(7)
Authors: Sprengers, D.; van der Molen, R. G.; Binda, R.; Kusters, J. G.; de Man, R. A.; Niesters, H. G. M.; Schalm, S. W.; Janssen, H. L. A.